|

Olanzapine 2.5 MG Clinical Trials

2 actively recruiting trials

Also known as: OLN2.5

Pipeline

Phase 3: 2

Top Sponsors

  • Qinghai Red Cross Hospital1
  • Mahidol University1

Indications

  • Cancer2
  • Olanzapine1
  • Anorexia1
  • Weight Loss1
  • Progression-free Survival1

Other2 trials

Olanzapine for Cancer Related Anorexia-cachexia Syndrome
Phase 3
Survival With Olanzapine in Patients With Locally Advanced or Metastatic Upper Gastrointestinal and Lung Cancer
Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.